⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
JNJ News
Johnson & Johnson
Global Diabetic Eye Disease Devices Market Forecast (2025-2032) Featuring Strategic Analysis of Carl Zeiss, Topcon, Heidelberg Engineering, NIDEK, Canon Medical Systems and More - ResearchAndMarkets.com
businesswire.com
TOPC
NC
ALC
BLCO
JNJ
Surgical Robots Market worth $27.14 billion by 2030 | MarketsandMarkets™
prnewswire.com
ISRG
STX
MD
SN
ZBH
JNJ
Medical Devices Market Worth USD 955 Billion by 2030 as Conventional Devices Lead and AR/VR Platforms Grow at 7.78% CAGR, Says Mordor Intelligence
globenewswire.com
MDT
GEHC
PHG
ABT
HON
ZBH
SYK
JNJ
Unprecedented results from the Phase 3 MajesTEC-3 study support TECVAYLI®▼ (teclistamab) plus DARZALEX® (daratumumab) subcutaneous formulation as a potential standard of care as early as second line for patients with relapsed/refractory multiple myeloma
globenewswire.com
JNJ
Unprecedented results from the Phase 3 MajesTEC-3 study support TECVAYLI® plus DARZALEX FASPRO® as a potential standard of care as early as second line for patients with relapsed/refractory multiple myeloma
prnewswire.com
JNJ
Tec-Dara Combination Offers Substantial Improvement Over Standard Second-Line Therapies for Relapsed or Refractory Multiple Myeloma
prnewswire.com
JNJ
REGN
Senior Pharma and Biotech Leaders to Convene for Industry Forum at San Francisco CEO Ahead of JP Morgan Healthcare Conference
accessnewswire.com
JPM
JNJ
AMGN
MRK
BMY
REGN
Medical Aesthetic Devices Market Projected to Reach $37.9 Billion by 2029
globenewswire.com
JNJ
BHC
ABBV
Hagens Berman Sobol Shapiro LLP and Lowey Dannenberg, P.C. Announce Certification of a Class of Third Party Payors Who Purchased or Paid for Some or All of the Price of Stelara
prnewswire.com
JNJ
Johnson & Johnson to Participate in the 44 th Annual J.P. Morgan Healthcare Conference
businesswire.com
JNJ